London, January 12, 2016 - International liver cancer guidelines could be preventing patients from getting life-saving treatments in developing countries, according to a new study published in the journal Heliyon. The authors of the research are calling for treatment guidelines that are more tailored to developing countries, to help save lives.
Hepatocellular carcinoma is the most common type of liver cancer, accounting for approximately 75% of all primary liver cancer cases. Globally, it causes 745,000 deaths a year, making it the second most lethal cancer in the world.